References
- Atanasoski S., Boller D., De Ventura L., Koegel H., Boentert M., Young P., et al. Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation. Glia 2006; 53: 147–157
- Au E., Richter M. W., Vincent A. J., Tetzlaff W., Aebersold R., Sage E. H., et al. SPARC from olfactory ensheathing cells stimulates Schwann cells to promote neurite outgrowth and enhances spinal cord repair. J Neurosci 2007; 27: 7208–7221
- Banerjee S. A., Patterson P. H. Schwann cell CD9 expression is regulated by axons. Mol Cell Neurosci 1995; 6: 462–473
- Bienfait H. M. E., Baas F., Koelman J. H. T. M., de Haan R. J., van Engelen B. G. M., Gabreëls-Festen A. A. W. M., et al. Phenotype of Charcot-Marie-Tooth disease type 2. Neurology 2007; 68: 1658–1667
- Bosse F., Hasenpusch-Theil K., Kury P., Muller H. W. Gene expression profiling reveals that peripheral nerve regeneration is a consequence of both novel injury-dependent and reactivated developmental processes. J Neurochem 2006; 96: 1441–1457
- Braunewell K. H., Martini R., LeBaron R., Kresse H., Faissner A., Schmitz B., et al. Upregulation of a chondroitin sulphate epitope during regeneration of mouse sciatic nerve: evidence that the immunoreactive molecules are related to the chondroitin sulphate proteoglycans decorin and versican. Eur J Neurosci 1995; 7: 792–804
- Cao W., Epstein C., Liu H., DeLoughery C., Ge N., Lin J., et al. Comparing gene discovery from Affymetrix GeneChip microarrays and Clontech PCR-select cDNA subtraction: a case study. BMC Genom 2004; 27: 26–36
- Giambonini-Brugnoli G., Buchstaller J., Sommer L., Suter U., Mantei N. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation. Neurobiol Dis 2004; 18: 656–668
- Gillen C., Gleichmann M., Spreyer P., Muller H. W. Differentially expressed genes after peripheral nerve injury. J Neurosci Res 1995; 42: 159–171
- Gupta R., Rummler L. S., Palispis W., Truong L., Chao T., Rowshan K., et al. Local downregulation of myelin-associated glycoprotein permits axonal sprouting with chronic nerve compression injury. Exp Neurol 2006; 200: 418–429
- Jones L. L., Liu Z., Shen J., Werner A., Kreutzberg G. W., Raivich G. Regulation of the cell adhesion molecule CD44 after nerve transection and direct trauma to the mouse brain. J Comp Neurol 2000; 426: 468–492
- Maier M., Berger P., Nave K-A., Suter U. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves. MCN 2002; 20: 93–109
- Pareyson D., Scaioli V., Laura M. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromol Med 2006; 8: 3–22
- Pennuto M., Tinelli E., Malaguti M. C., Del Carro U., D'Antonio M., Ron D., et al. Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice. Neuron 2008; 57: 393–405
- Szpara M. L., Vranizan K., Tai Y. C., Goodman C. S., Speed T. P., Ngai J. Analysis of gene expression during neurite outgrowth and regeneration. BMC Neurosci 2007; 8: 100
- Zuchner S., Vance J. M. Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies. Nat Clin Pract Neurol 2006; 2: 45–53